|
1
|
Hori S, Nomura T and Sakaguchi S: Control
of regulatory T cell development by the transcription factor Foxp3.
Science. 299:1057–1061. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fontenot JD, Gavin MA and Rudensky AY:
Foxp3 programs the development and function of
CD4+CD25+ regulatory T cells. Nat Immunol.
4:330–336. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Khattri R, Cox T, Yasayko SA and Ramsdell
F: An essential role for Scurfin in CD4+CD25+
T regulatory cells. Nat Immunol. 4:337–342. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nomura T and Sakaguchi S: Naturally
arising CD25+CD4+ regulatory T cells in tumor
immunity. Curr Top Microbiol Immunol. 293:287–302. 2005.
|
|
5
|
Gilliet M and Liu Y: Human
plasmacytoid-derived dendritic cells and the induction of
T-regulatory cells. Hum Immunol. 63:1149–1155. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Moseman EA, Liang X, Dawson AJ, et al:
Human plasmacytoid dendritic cells activated by CpG
oligodeoxynucleotides induce the generation of
CD4+CD25+ regulatory T cells. J Immunol.
173:4433–4442. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sun CM, Hall JA, Blank RB, et al: Small
intestine lamina propria dendritic cells promote de novo generation
of Foxp3 T reg cells via retinoic acid. J Exp Med. 204:1775–1785.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Palucka K, Ueno H, Fay J and Banchereau J:
Dendritic cells and immunity against cancer. J Intern Med.
269:64–73. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tarbell KV, Petit L, Zuo X, Toy P, et al:
Dendritic cell-expanded, islet-specific
CD4+CD25+CD62L+ regulatory T cells
restore normoglycemia in diabetic NOD mice. J Exp Med. 204:191–201.
2007.PubMed/NCBI
|
|
10
|
Dhodapkar MV and Steinman RM:
Antigen-bearing immature dendritic cells induce peptide-specific
CD8(+) regulatory T cells in vivo in humans. Blood. 100:174–177.
2002.PubMed/NCBI
|
|
11
|
Liu YJ: A unified theory of central
tolerance in the thymus. Trends Immunol. 27:215–221. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yamazaki S, Patel M, Harper A, et al:
Effective expansion of alloantigen-specific Foxp3+
CD25+ CD4+ regulatory T cells by dendritic
cells during the mixed leukocyte reaction. Proc Natl Acad Sci USA.
103:2758–2763. 2006.PubMed/NCBI
|
|
13
|
Banerjee DK, Dhodapkar MV, Matayeva E, et
al: Expansion of FOXP3 high regulatory T cells by human dendritic
cells (DCs) in vitro and after injection of cytokine-matured DCs in
myeloma patients. Blood. 108:2655–2661. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Brunkow ME, Jeffery EW, Hjerrild KA, et
al: Disruption of a new forkhead/winged-helix protein, scurfin,
results in the fatal lymphoproliferative disorder of the scurfy
mouse. Nat Genet. 27:68–73. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Woo EY, Chu CS, Goletz TJ, et al:
Regulatory CD4(+)CD25(+) T cells in tumors from patients with
early-stage non-small cell lung cancer and late-stage ovarian
cancer. Cancer Res. 61:4766–4772. 2001.
|
|
16
|
Liyanage UK, Moore TT, Joo HG, et al:
Prevalence of regulatory T cells is increased in peripheral blood
and tumor microenvironment of patients with pancreas or breast
adenocarcinoma. J Immunol. 169:2756–2761. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Curiel TJ, Coukos G, Zou L, et al:
Specific recruitment of regulatory T cells in ovarian carcinoma
fosters immune privilege and predicts reduced survival. Nat Med.
10:942–949. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Viguier M, Lemaitre F, Verola O, et al:
Foxp3 expressing CD4+CD25(high) regulatory T cells are
overrepresented in human metastatic melanoma lymph nodes and
inhibit the function of infiltrating T cells. J Immunol.
173:1444–1453. 2004.PubMed/NCBI
|
|
19
|
Wang HY, Lee DA, Peng G, et al:
Tumor-specific human CD4+ regulatory T cells and their
ligands: implications for immunotherapy. Immunity. 20:107–118.
2004. View Article : Google Scholar
|
|
20
|
Wang HY, Peng G, Guo Z, et al: Recognition
of a new ARTC1 peptide ligand uniquely expressed in tumor cells by
antigen-specific CD4+ regulatory T cells. J Immunol.
174:2661–2670. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sato E, Olson SH, Ahn J, et al:
Intraepithelial CD8+ tumor-infiltrating lymphocytes and
a high CD8+/regulatory T cell ratio are associated with
favorable prognosis in ovarian cancer. Proc Natl Acad Sci USA.
102:18538–18543. 2005.
|
|
22
|
Valzasina B, Piconese S, Guiducci C and
Colombo MP: Tumor-induced expansion of regulatory T cells by
conversion of CD4+CD25− lymphocytes is thymus
and proliferation independent. Cancer Res. 66:4488–4495. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rolle CE, Sengupta S and Lesniak MS:
Mechanisms of immune evasion by gliomas. Adv Exp Med Biol.
746:53–76. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Vinay DS, Kim CH, Choi BK and Kwon BS:
Origins and functional basis of regulatory CD11c+
CD8+ T cells. Eur J Immunol. 39:1552–1563. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tsujitani S, Kakeji Y, Watanabe A, et al:
Infiltration of dendritic cells in relation to tumor invasion and
lymph node metastasis in human gastric cancer. Cancer.
66:2012–2016. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Schuler PJ, Börger V, Bölke E, et al:
Dendritic cell generation and CD4+ CD25 high
FOXP3+ regulatory T cells in human head and neck
carcinoma during radio-chemotherapy. Eur J Med Res. 16:57–62.
2011.PubMed/NCBI
|
|
27
|
Cochran AJ, Huang RR, Lee J, et al:
Tumor-induced immune modulation of sentinel lymph nodes. Nat Rev
Immunol. 6:659–670. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Munn DH and Mellor AL: The tumor-draining
lymph node as an immune-privileged site. Immunol Rev. 213:146–158.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shurin MR, Shurin GV, Lokshin A, et al:
Intratumoral cytokines/chemokines/growth factors and tumor
infiltrating dendritic cells: friends or enemies? Cancer Metastasis
Rev. 25:333–356. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zou W, Machelon V, Coulomb-L’Hermin A, et
al: Stromal-derived factor-1 in human tumors recruits and alters
the function of plasmacytoid precursor dendritic cells. Nat Med.
7:1339–1346. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sharma MD, Baban B, Chandler P, et al:
Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes
directly activate mature Tregs via indoleamine 2,3-dioxygenase. J
Clin Invest. 117:2570–2582. 2007. View
Article : Google Scholar
|
|
32
|
Hubert P, Jacobs N, Caberg JH, et al: The
cross-talk between dendritic and regulatory T cells: good or evil?
J Leukoc Biol. 82:781–794. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Battaglia A, Buzzonetti A, Baranello C, et
al: Metastatic tumour cells favour the generation of a tolerogenic
milieu in tumour draining lymph node in patients with early
cervical cancer. Cancer Immunol Immunother. 58:1363–1373. 2009.
View Article : Google Scholar : PubMed/NCBI
|
